Cargando…

Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology

Vaccination programs with the current prophylactic HPV vaccines started in most countries around 2008 with introduction of the bivalent Cervarix HPV16/18 vaccine, rapidly followed by Gardasil (HPV6/11/16/18) and, finally, Gardasil 9 (HPV6/11/16/18/31/33/45/52/58), from 2015. Many studies have now co...

Descripción completa

Detalles Bibliográficos
Autor principal:	Hampson, Ian N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029410/ https://www.ncbi.nlm.nih.gov/pubmed/35458487 http://dx.doi.org/10.3390/v14040757

Ejemplares similares

High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine
por: Hooi, Desiree J, et al.
Publicado: (2018)

The Effect of Prophylactic HPV Vaccines on Oral and Oropharyngeal HPV Infection—A Systematic Review
por: Nielsen, Kristoffer Juul, et al.
Publicado: (2021)

Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development
por: Pinto, Ligia A., et al.
Publicado: (2018)

Explanations for the high potency of HPV prophylactic vaccines
por: Schiller, John, et al.
Publicado: (2018)

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening
por: Coupé, V M H, et al.
Publicado: (2008)

Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives
por: Mo, Yicheng, et al.
Publicado: (2022)

Sound efficacy of prophylactic HPV vaccination: Basics and implications
por: Lehtinen, Matti, et al.
Publicado: (2012)

Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines
por: Cuschieri, K, et al.
Publicado: (2010)

Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia
por: Sabol, Ivan, et al.
Publicado: (2017)

Mathematical Model of HPV Provides Insight into Impacts of Risk Factors and Vaccine
por: Kim, Jane J
Publicado: (2006)

Can prophylactic HPV vaccination reduce the recurrence of cervical lesions after surgery? Review and prospect
por: Han, Ling, et al.
Publicado: (2023)

Prevalence and genotype distribution of HPV and cervical pathological results in Sichuan Province, China: a three years surveys prior to mass HPV vaccination
por: Luo, Qing, et al.
Publicado: (2020)

Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali
por: Téguété, Ibrahima, et al.
Publicado: (2017)

Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer
por: Stanley, M
Publicado: (2007)

HPV Prophylactic Vaccination in Males Improves the Clearance of Semen Infection()
por: Foresta, Carlo, et al.
Publicado: (2015)

HPV pathogenesis, various types of vaccines, safety concern, prophylactic and therapeutic applications to control cervical cancer, and future perspective
por: Ashique, Sumel, et al.
Publicado: (2023)

High Prevalence of HPV 51 in an Unvaccinated Population and Implications for HPV Vaccines
por: Bowden, Sarah J., et al.
Publicado: (2022)

Prevalence of cervical infection with HPV type 16 and 18 in Vietnam: implications for vaccine campaign
por: Vu, Lan TH, et al.
Publicado: (2013)

HPV and cervical cancer: screening or vaccination?
por: Bosch, F X, et al.
Publicado: (2008)

Cervical cancer in India and HPV vaccination
por: Kaarthigeyan, K.
Publicado: (2012)

Cervical Cancer HPV Vaccination and Bhutan
por: Hingmire, Sachin, et al.
Publicado: (2023)

Knowledge and Awareness of Cervical Cancer, Human Papillomavirus (HPV), and HPV Vaccine Among HPV-Infected Chinese Women
por: Baloch, Zulqarnain, et al.
Publicado: (2017)

Prevalence of HPV and Assessing Type-Specific HPV Testing in Cervical High-Grade Squamous Intraepithelial Lesions in Poland
por: Przybylski, Marcin, et al.
Publicado: (2023)

Alterations of HPV-Related Biomarkers after Prophylactic HPV Vaccination. A Prospective Pilot Observational Study in Greek Women
por: Valasoulis, George, et al.
Publicado: (2020)

An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway
por: Enerly, Espen, et al.
Publicado: (2019)

The new screening program to prevent cervical cancer using HPV DNA: getting the balance right in maintaining quality
por: Garland, Suzanne M, et al.
Publicado: (2018)

Effectiveness of quadrivalent HPV vaccination in reducing vaccine-type and nonvaccine-type high risk HPV infection
por: Li, Chenxi, et al.
Publicado: (2023)

Awareness and Knowledge of HPV, HPV Vaccination, and Cervical Cancer among an Indigenous Caribbean Community
por: Warner, Zachary Claude, et al.
Publicado: (2022)

Correction: An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway
Publicado: (2019)

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
por: Kavanagh, K, et al.
Publicado: (2014)

HPV prevalence and type distribution in Cypriot women with cervical cytological abnormalities
por: Krashias, George, et al.
Publicado: (2017)

HPV negative cervical cancers and primary HPV screening
por: Tjalma, WAA
Publicado: (2018)

Oral HPV prevalence and HPV vaccination among special needs population in the US
por: Chandrupatla, Siddardha G., et al.
Publicado: (2019)

Therapeutic Vaccination for HPV Induced Cervical Cancers
por: Brinkman, Joeli A., et al.
Publicado: (2007)

Does HPV vaccination prevent cervical cancer?
por: Miller, Anthony B.
Publicado: (2013)

Comment on “Will HPV vaccination prevent cervical cancer”
por: Zhang, Shaokai, et al.
Publicado: (2020)

Cervical Cancer Screening and HPV Vaccination in Nepal
por: Baral, Gehanath, et al.
Publicado: (2023)

Special Issue: HPV and HPV Vaccines
por: Hibma, Merilyn
Publicado: (2022)

HPV vaccination bridges to HPV screening
por: Harper, Diane M, et al.
Publicado: (2020)

Serum and cervicovaginal IgG immune responses against α7 and α9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_203ltngsd6bfe3rcnql1unsg2j